Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125838982 | 12583898 | 2 | F | 201606 | 20160727 | 20160722 | 20160804 | EXP | US-UNITED THERAPEUTICS-UNT-2016-010678 | UNITED THERAPEUTICS | 30.49 | YR | F | Y | 45.35000 | KG | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125838982 | 12583898 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.010 ?G/KG, CONTINUING | 2100955 | 21272 | .01 | UG/KG | INJECTION | ||||||
| 125838982 | 12583898 | 2 | SS | LASIX | FUROSEMIDE | 1 | Unknown | 60 MG, QD | U | U | 0 | 60 | MG | QD | |||||
| 125838982 | 12583898 | 3 | SS | LASIX | FUROSEMIDE | 1 | Unknown | 40 MG, QD | U | U | 0 | 40 | MG | QD | |||||
| 125838982 | 12583898 | 4 | SS | LASIX | FUROSEMIDE | 1 | Unknown | 20 MG, QD | U | U | 0 | 20 | MG | QD | |||||
| 125838982 | 12583898 | 5 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1504768A | 0 | 10 | MG | TABLET | QD | |||||
| 125838982 | 12583898 | 6 | C | REVATIO | SILDENAFIL CITRATE | 1 | 0 | ||||||||||||
| 125838982 | 12583898 | 7 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 125838982 | 12583898 | 8 | C | METOLAZONE. | METOLAZONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125838982 | 12583898 | 1 | Pulmonary arterial hypertension |
| 125838982 | 12583898 | 2 | Oedema |
| 125838982 | 12583898 | 5 | Product used for unknown indication |
| 125838982 | 12583898 | 6 | Product used for unknown indication |
| 125838982 | 12583898 | 7 | Product used for unknown indication |
| 125838982 | 12583898 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125838982 | 12583898 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125838982 | 12583898 | Abdominal distension | |
| 125838982 | 12583898 | Ascites | |
| 125838982 | 12583898 | Epistaxis | |
| 125838982 | 12583898 | Feeling of body temperature change | |
| 125838982 | 12583898 | Oedema peripheral | |
| 125838982 | 12583898 | Oxygen saturation decreased | |
| 125838982 | 12583898 | Productive cough | |
| 125838982 | 12583898 | Rales | |
| 125838982 | 12583898 | Urine abnormality | |
| 125838982 | 12583898 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125838982 | 12583898 | 1 | 20160623 | 0 | ||
| 125838982 | 12583898 | 2 | 20160628 | 0 | ||
| 125838982 | 12583898 | 3 | 20160629 | 0 |